Ivabradine and the anti-inflammatory effects in patients with ischemic heart disease

被引：4
作者：
Dominguez-Rodriguez, Alberto [1 ,2 ]
Abreu-Gonzalez, Pedro [3 ]
机构：
[1] Hosp Univ Canarias, Serv Cardiol, Tenerife, Spain
[2] Univ Europea Canarias, Fac Ciencias Salud, La Orotava, Santa Cruz De T, Spain
[3] Univ La Laguna, Dept Ciencias Med Basicas, Unidad Fisiol, Santa Cruz De Tenerife, Spain
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 221卷
关键词：
Angina pectoris; Anti-anginal drug; Ivabradine; Coronary artery disease; Anti-inflammatory; ACUTE CORONARY SYNDROMES; C-REACTIVE PROTEIN; RATE REDUCTION; ATHEROSCLEROSIS; INFLAMMATION; DYSFUNCTION; MORTALITY; RISK;
D O I：
10.1016/j.ijcard.2016.07.096
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：627 / 628
页数：2
相关论文
共 13 条
  • [1] Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
    Baumhaekel, Magnus
    Custodis, Florian
    Schlimmer, Nils
    Laufs, Ulrich
    Boehm, Michael
    [J]. ATHEROSCLEROSIS, 2010, 212 (01) : 55 - 62
  • [2] Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction
    Camici, Paolo G.
    Gloekler, Steffen
    Levy, Bernard I.
    Skalidis, Emmanouil
    Tagliamonte, Ercole
    Vardas, Panos
    Heusch, Gerd
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 1 - 6
  • [3] Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice
    Custodis, Florian
    Baumhaekel, Magnus
    Schlimmer, Nils
    List, Franka
    Gensch, Christoph
    Boehm, Michael
    Laufs, Ulrich
    [J]. CIRCULATION, 2008, 117 (18) : 2377 - 2387
  • [4] Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation
    Dominguez-Rodriguez, A.
    Abreu-Gonzalez, P.
    Kaski, J. C.
    [J]. CURRENT DRUG TARGETS, 2009, 10 (10) : 1001 - 1008
  • [5] Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study
    Dominguez-Rodriguez, Alberto
    Consuegra-Sanchez, Luciano
    Blanco-Palacios, Gabriela
    Abreu-Gonzalez, Pedro
    Sanchez-Grande, Alejandro
    Bosa-Ojeda, Francisco
    Kaski, Juan Carlos
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) : 160 - 162
  • [6] Increased heart rate and atherosclerosis: Potential implications of ivabradine therapy
    Dominguez-Rodriguez, Alberto
    Blanco-Palacios, Gabriela
    Abreu-Gonzalez, Pedro
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2011, 3 (04): : 101 - 104
  • [7] Heart rate variability and progression of coronary atherosclerosis
    Huikuri, HV
    Jokinen, V
    Syvänne, M
    Nieminen, MS
    Airaksinen, KEJ
    Ikäheimo, MJ
    Koistinen, JM
    Kauma, H
    Kesäniemi, AY
    Majahalme, S
    Niemelä, KO
    Frick, MH
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (08) : 1979 - 1985
  • [8] HEART-RATE AND CARDIOVASCULAR MORTALITY - THE FRAMINGHAM-STUDY
    KANNEL, WB
    KANNEL, C
    PAFFENBARGER, RS
    CUPPLES, LA
    [J]. AMERICAN HEART JOURNAL, 1987, 113 (06) : 1489 - 1494
  • [9] Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein
    Koenig, W
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (02) : 199 - 206
  • [10] C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy
    Morrow, DA
    Rifai, N
    Antman, EM
    Weiner, DL
    McCabe, CH
    Cannon, CP
    Braunwald, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) : 1460 - 1465
12